Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
The Cochrane Database of Systematic Reviews|August 10, 2018
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adultsXavier Castells, Lídia Blanco-Silvente, Ruth Cunill
Adicciones|July 12, 2016
The treatment of dual ADHD: a drop in the oceanRuth Cunill, Xavier Castells
Medicina Clinica|May 3, 2014
[Attention deficit hyperactivity disorder]Ruth Cunill, Xavier Castells
BMC Geriatrics|July 26, 2018
Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patientsLídia Blanco-Silvente, Dolors Capellà, Josep Garre-Olmo, et al.
European Journal of Clinical Pharmacology|September 18, 2012
Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trialsXavier Castells, Ruth Cunill, Dolors Capellà
The Journal of Clinical Psychiatry|February 5, 2009
Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysisRuth Cunill, Xavier Castells, Daphne Simeon
Psychiatry Research|July 2, 2013
The effect of obsessive-compulsive symptomatology on executive functions in schizophrenia: a systematic review and meta-analysisRuth Cunill, Elena Huerta-Ramos, Xavier Castells
Pharmacoepidemiology and Drug Safety|July 2, 2013
Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regressionRuth Cunill, Xavier Castells, Aurelio Tobias, et al.
European Journal of Clinical Pharmacology|August 23, 2019
Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysisLídia Blanco-Silvente, Xavier Castells, Josep Garre-Olmo, et al.
The International Journal of Neuropsychopharmacology|February 16, 2017
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 PatientsLídia Blanco-Silvente, Xavier Castells, Marc Saez, et al.
Pageof 23